␣-adrenergic; methoxamine; volume; hyperosmotic stress; bumetanide; shrinkage; cystic fibrosis; rottlerin NA-K-2CL COTRANSPORTERS (NKCCS) comprise a family of Cl Ϫ -dependent cation cotransporters that are expressed in many animal cells (24) . This widespread distribution suggests a fundamental role for NKCCs in physiological functions. In most cells that have been well studied, NKCCs are activated by cell shrinkage and thus play a potentially critical role in cell-volume regulation. Epithelia NKCCs serve secretory and absorptive functions depending on the localization of the NKCC to the basolateral or apical plasma membrane, respectively. Absorptive functions of NKCCs are best observed in the absorptive epithelium of the thick ascending limb of Henle's loop of mammalian kidney. Secretory functions are well studied in a number of epithelia including those of the colon, trachea, small intestine, and salivary gland (24) .
Bumetanide-sensitive NKCC1 is localized to the basolateral plasma membrane of epithelia and participates in homeostatic control of cell volume and secretion of fluids and electrolytes. In epithelia of the colon and trachea, for example, Cl Ϫ secretion is rapidly elicited by agents that act on cAMP. cAMP-mediated activation of apical Cl Ϫ channels is generally modeled as the major regulatory event to elicit secretion. However, basolateral NKCC1 is necessary for secretion because it supplies Cl Ϫ for secretion. The intracellular Cl Ϫ concentration ([Cl Ϫ ] i ) itself has been linked to regulation of NKCC1 activity in secretory epithelia and avian erythrocytes (22, 24) as well as in dialyzed squid axon (1) . In general, a reduction in intracellular Cl Ϫ (Cl i Ϫ ) appears to stimulate NKCC1, whereas elevation of Cl i Ϫ appears to inhibit NKCC1. Models based on these findings depict Cl Ϫ secretion as a coordinated control of Cl Ϫ exit at the apical membrane through Cl Ϫ channels and entry at the basolateral membrane through NKCC1. However, the mechanism by which [Cl Ϫ ] i regulates NKCC1 activity is not well understood.
One mechanism that is thought to control activity of NKCC1 is NKCC1 phosphorylation through the action of serine and threonine protein kinases. NKCC1 isoforms from mammalian epithelia share similar putative sites for phosphorylation by protein kinases A and C (PKA and PKC; Ref. 24 ). Yet elevations in PKA alone do not fully explain the activation of NKCC1 in shark rectal gland cells and human tracheal epithelial cells (9) . Rather, we have shown that activation of NKCC1 in human tracheal epithelial cells and in a Calu-3 cell line can be isolated from activation of Cl Ϫ channels through stimulation with an ␣ 1 -adrenergic agonist (9, 10, 12) . Our studies also demonstrate a signaling mechanism in which PKC-␦ is required for ␣ 1 -adrenergic activation of NKCC1 (11) . An earlier study (8) on rabbit tracheal epithelial cells showed that NKCC1 is activated by hyperosmotic stress, which causes a rapid loss of water and leads to cell shrinkage and subsequent compensatory uptake of ions via NaCl or NKCC.
In this study, we investigated the sensitivity of human airway epithelial NKCC1 activity and PKC-␦ activity to [ Cl Ϫ ] i in Calu-3 cells. A Calu-3 epithelial cell line has been shown by others and by us to express NKCC1 mRNA and hormone-mediated activation of NKCC1 (4, 10) . We first identified experimental conditions that allow alterations in Cl i Ϫ while minimizing changes in cell volume. The results show that cell volume in Calu-3 cells is differentially altered by hormone stimulation with methoxamine (an ␣ 1 -adrenergic agonist) and by hyperosmolarity induced using sucrose. Next, we studied the effects of varying [ 
MATERIALS AND METHODS
Cell culture. Calu-3 cells were grown in cell culture in Earle's balanced salt solution supplemented with 2.4 mM L-glutamine and 10% fetal bovine serum on 0.4-m pore size Transwell-Clear polyester filter inserts (Corning Costar, Cambridge, MA). For measurement of cell volume and transepithelial flux, cells were seeded at a density of 2.0 ϫ 10 6 cells onto filters with a growth area of 4.52 cm 2 . Cells were incubated in a humidified CO2 incubator at 37°C. Culture medium was changed at 48-h intervals until confluence was reached. Confluence was assessed by microscopic examination of the cell monolayer and by measurement of electrical resistance across the cell monolayer. Transepithelial resistance was quantitated using chopstick electrodes and an epithelial voltohmmeter (EVOM, World Precision Instruments, New Haven, CT). Values were corrected for background resistance of the filter alone bathed in medium. Cell monolayers were serum deprived for 18 h before the experiments.
Measurement of Cl i Ϫ and intracellular volume. The equilibrium distribution of [ 14 C]urea was used to measure intracellular water space, and that of 36 Cl was used to measure intracellular content. After incubation overnight in serumfree culture medium, cell monolayers were washed twice in Hanks' balanced salt solution containing 10 mM HEPES with pH 7.4 (HPSS) and were incubated with HPSS containing 0.4 Ci of [
14 C]urea and 1 Ci of 36 Cl for 1 h. Cells were exposed to vehicle, 10 M methoxamine, or sufficient sucrose to raise medium osmolarity to 500 mosmol/kgH 2O for the time intervals indicated in the table and figure legends. Radiotracer flux was terminated by washing the cell monolayer rapidly four times in ice-cold isotonic sucrose (100 mM MgSO 4 and 137 mM sucrose) (12) . Intracellular radioactivity was extracted by incubating cells in 0.1 N NaOH. Radioactivity in an aliquot of extract was determined by scintillation counting, and protein content was measured by the Bradford protein assay using bovine serum albumin as the standard. 86 Rb, a congener of K, as previously described (13) . Cell monolayers were preincubated for 10 min at 37°C with HPSS or HPSS supplemented with 10 M bumetanide or 10 M rottlerin in a basolateral bathing solution. Cells were permeabilized at the apical membrane using 175 U/ml nystatin in an apical cytosolic medium containing (in mM) 20 To initiate transepithelial flux, 1 Ci of 86 Rb was added to the basolateral solution. The apical bathing medium was collected for radioactive counts at 2.5-min intervals for 10 min and replaced with an equal volume of nystatin-supplemented cytosolic medium. At 10 min, methoxamine was added to the basolateral solution to a final concentration of 10 M, and sampling continued at 2.5-min intervals for 10 min. After the last sampling, cell monolayers were washed in 1% PBS and extracted with 0.5 ml of 0.1 N NaOH. Aliquots of the cell extract were assayed for protein content. The accumulation of 86 Rb in the apical compartment was calculated (as nmol/mg of protein) over time.
Immunoprecipitation, PKC activity assay, and Western blot analysis of PKC isotypes. Calu-3 cells were grown on filter inserts before being serum deprived and preequilibrated with an apical perfusate containing 225 U of nystatin/ ml, 20 mM Na ϩ , 110 mM K ϩ , 0.4 mM Mg 2ϩ , 4.2 mM HCO 3 Ϫ , and 10 mM HEPES at pH 7.5 and varying [Cl Ϫ ] as described (see Measurement of NKCC1 activity). Cells were then stimulated with methoxamine or, as a control, with vehicle of HPSS. Cells were rapidly immersed in ice-cold PBS to halt the stimulation and were harvested in 1 ml of lysis buffer consisting of 100 mM NaCl, 50 mM NaF, 50 mM Tris ⅐ HCl, pH 7.55, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, and the protease inhibitors as described. Lysates were clarified by microcentrifugation at 4°C for 20 min at 12,000 g and incubated with antiserum against a specific PKC isotype as previously described (13) . Immune complexes were recovered using protein G agarose beads that were prewashed and resuspended in lysis buffer. Western blot analysis of immunoprecipitated protein was used to titrate antiserum and select an optimal antiserum concentration (13) . Kinase activity of PKC isotypes was measured by taking immunoprecipitates to a final volume of 50 l in assay mixture {50 mM Tris ⅐ HCl, pH 7.5, 10 mM ␤-mercaptoethanol, 10 mM MgSO4, 40 g/ml phosphatidylserine, 0.1 M phorbol 12-myristate 13-acetate (PMA), 50 M ATP, 10 g/ml histone III, 3 Ci of [␥-
32 P]ATP, 1 mM sodium orthovanadate, and protease inhibitors} and incubating at 30°C for 15 min. The reaction was terminated by addition of 30 l of glacial acetic acid. A 40-l aliquot was spotted on P-81 phosphocellulose paper, washed, and counted for radioactivity using Cerenkov counting.
For studies on the distribution of PKC isotypes, cells were grown to confluence on filter inserts and incubated overnight in serum-free media. [Cl Ϫ ]i was varied as described. After treatment with vehicle (for 1 or 10 min), methoxamine (for 1 min), or sucrose (for 10 min), cell monolayers were immediately washed twice with ice-cold PBS, harvested in 1 ml of ice-cold hypotonic buffer, and fractionated as previously described (11) . Aliquots of subcellular fractions were solubilized in SDS-Laemmli buffer and subjected to gel electrophoresis on 4-15% gradient slab gels. Protein bands were transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Bedford, MA) and immunoblotted with polyclonal antibodies to specific PKC isotypes. Immunoreactive protein bands were detected using enhanced chemiluminescence and quantitated by laser densitometry. Preliminary experiments showed that antibody to PKC-␦ did not recognize PKC-and vice versa.
NKCC1 was immunoprecipitated according to the method of D'Andrea and colleagues (3) with modifications. In brief, Calu-3 cells were lysed in 1 ml of ice-cold 10 mM HEPES buffer (pH 7.4) supplemented with 3.5 mM MgCl2, 150 mM NaCl, 1 mM benzamide, and protease inhibitors. The lysate was clarified by microcentrifugation for 10 min at 4°C. A 0.5-ml aliquot of supernatant was incubated with 1.1% SDS for 1 h at room temp. The SDS-solubilized lysates were combined with 1.4 ml of 3.0% Triton X-100 in lysis buffer and incubated for 1 h on ice. NKCC1 was immunoprecipitated by overnight incubation at 4°C with 1:2,500 dilution of T4 monoclonal antibody (15) . Immune complexes were recovered using protein G agarose beads that had been prewashed and resuspended in lysis buffer. The immune complexes were recovered by centrifugation, washed five times, and subjected to gel electrophoresis on 4-15% gradient slab gels. NKCC1 and coimmunoprecipitated proteins were detected by Western blot analysis using specific antibodies and enhanced chemiluminescence as previously described (10, 11 Transwell-Clear filter inserts were purchased from Fisher Scientific. Polyclonal anti-PKC isotype-specific antibodies were obtained from Santa Cruz Biotechnology, and recombinant PKC isotypes were from Calbiochem (La Jolla, CA). T4 monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank. Methoxamine-HCl, bumetanide, and nystatin were purchased from Sigma Chemical and rottlerin was from Research Products International (Natick, MA). All other chemicals were reagent grade.
RESULTS

Modulation of Cl i
Ϫ and V i levels by ␣-adrenergic stimulation. To measure changes in Cl i Ϫ and V i levels, the respective values were measured by equilibrium distribution of 36 Cl and [ Fig. 1 . We also calculated means for cumulative data, which are presented in Table 2 . Stimulation of Calu-3 cells with methoxamine resulted in a time-dependent increase in the ratios of Cl i Ϫ and V i , thereby indicating elevated Cl i Ϫ and V i levels. The data of Fig. 1 show that hormone stimulation rapidly increased the ratios of Cl i Ϫ and V i to attain maximal levels after 1 min of stimulation. Cl i Ϫ and V i then declined and reached baseline levels after 5 min of stimulation. At maximal levels, Cl i Ϫ increased 32.2 Ϯ 9.5% (n ϭ 4) and V i increased 31.2 Ϯ 7.0% (n ϭ 4). When cumulative data were examined, we found that methoxamine treatment also increased mean Cl i 11.2 Ϯ 1.9 l/mg of protein increased by 27.7% to 14.3 Ϯ 1.2 l/mg of protein. These increases are consistent with increases in the ratios of paired values (see Fig. 1 ), which suggests a pattern of increased V i and Cl i Ϫ values. Pretreatment of cell monolayers with bumetanide, an inhibitor of NKCC1, blocked the methoxamine-induced increase in the ratios of Cl i Ϫ and V i ( Fig. 1 ) and increased Cl i Ϫ and V i ( Table 2 ). These results indicate that NKCC1 is required for the effects of methoxamine on Cl i Ϫ and V i .
Ϫ and V i values by hyperosmotic stress. The results observed with methoxamine suggest that activation of NKCC1 results in elevated Cl i Ϫ values and cell swelling associated with elevated V i values. V i is also theoretically regulated, independent of Cl i Ϫ , by environmental stimuli such as hyperosmotic stress. In an earlier study (8), we reported that rabbit tracheal epithelial cells responded to hyperosmotic stress with elevated NKCC1 activity. Here we investigated the response to hyperosmotic stress on V i in human airway epithelial cells by adding sufficient sucrose to Calu-3 cells to increase medium osmolarity to 500 mosmol/kgH 2 O. Cl i Ϫ and V i levels were measured over a 30-min time frame as described in the Fig. 1 and Table 2 Ϫ reached a maximum of 18.3% after 5 min of stimulation and remained elevated at 10 min ( Fig. 2A and Table 2 ). Figure 2B shows that basolateral addition of sucrose significantly decreased V i levels for periods up to 10 min. The ratios of V i and Cl i Ϫ returned to baseline levels after 30 min of exposure to hyperosmotic medium. Bumetanide pretreatment blocked hyperosmotic-induced elevations in Cl i Ϫ and prolonged the return of V i values to baseline levels (Fig. 2B) . These results indicate that NKCC1 activity is necessary for the observed increase in Cl i Ϫ . In addition, the data demonstrate that the Calu-3 cells still retained the ability to shrink after addition of sucrose.
To gain more insight into the response to hyperosmotic stress, we examined mean values for Cl i Ϫ and V i from the set of experiments depicted in Fig. 2 . These data are presented in , which is 36.2 Ϯ 6% (n ϭ 7) of stimulated K ϩ flux. At this high Cl i Ϫ value, the rottlerin-sensitive methoxamine-stimulated flux was not significantly different from a bumetanide-sensitive methoxamine-stimulated flux of 345.8 Ϯ 50 nmol/mg of protein (n ϭ 5), which represented 49.6 Ϯ 3% (n ϭ 5) of stimulated K ϩ flux. These results support our earlier conclusion that activity of PKC-␦ is necessary for activation of NKCC1 (13) .
Modulation of in vivo PKC activity by [Cl
We have previously shown (11-13) that hormone stimulation rapidly increases activity of PKC-␦ and -and that the increased activity of PKC-␦ is necessary for activation of NKCC1. Our results from this study indicated that methoxamine also increases Cl i Ϫ (see Fig. 1 ), which suggests the possibility that activity of PKC-␦ might be sensitive to Cl i Ϫ . To evaluate this possibility, [Cl Ϫ ] i was varied in permeabilized cell monolayers using nystatin as described (see Measurement of NKCC1 activity). Increasing apical [Cl Ϫ ] i from 10 to 200 mM did not significantly affect baseline activity of PKC-␦ in cells that were treated with vehicle (Fig. 4) .
Basolateral application of the ␣ 1 -adrenergic agonist methoxamine induced a biphasic increase in activity of PKC-␦ (Fig. 4) . Peak levels were reached at [Cl 
03). At this Cl i
Ϫ level, methoxamine increased the activity of PKC-␦ by 2.4-fold, which corresponded to a 2.8-fold increase in NKCC1 activity. Indeed, for each increase in Cl i Ϫ , which supported a significant increase in agonist-stimulated activity of PKC-␦, there was also a significant increase in agonist-stimulated activity of NKCC1. The results indicate that, in the absence of cell shrinkage, there is a parallel stimulation of PKC-␦ and NKCC1.
Subcellular distribution of PKC isotypes in Calu-3 cells.
Our previous studies (11-13) of PKC-␦ distribution in human tracheal epithelial cells localized PKC-␦ to both cytosol and a Triton X-100 soluble particulate fraction. We examined the subcellular distribution of PKC-␦ and, because its activity also increases after ␣ 1 -adrenergic stimulation (10), we also investigated the distribution of PKC-in Calu-3 cells. The results are illustrated in Fig. 5 . At the endogenous [Cl Ϫ ] i of 47 mM, 54.5% of PKC-␦ and 37.6% of PKC-were localized to a particulate fraction. Decreasing Cl i Ϫ to 20 mM decreased the particulate localization of both PKC isotypes, and increasing Cl i Ϫ to 200 mM significantly increased particulate PKC-␦ and -levels. Methoxamine increased particulate PKC-␦ at 20 mM Cl i Ϫ to 76.1% and PKC-to 70.9%. Similarly, at 47 mM Cl i Ϫ , particulate PKC-␦ and -levels increased after methoxamine stimulation to 81.4 and 62.1%, respectively. At 200 mM Cl i Ϫ , the amount of each isotype localized to a particulate fraction did not change after methoxamine stimulation, which indicates that maximal translocation of a PKC isotype to a particulate fraction had already occurred.
Simultaneous ␣-adrenergic activation of NKCC1 and PKC-␦ at a specific Cl i Ϫ level suggests that PKC-␦ and NKCC1 might be closely associated. To examine this possibility, we immunoprecipitated NKCC1 and probed the immune complexes for PKC-␦ and vice versa using Western blot analysis. The results, shown in Fig. 6 , demonstrate that at least seven protein bands ranging from 32 to 190 kDa are detected in the immune complexes of NKCC1. NKCC1 is detected as a broad band between 130 and 170 kDa. The lower molecular mass band might represent an incompletely glycosylated protein. The higher molecular mass band is thought to represent a fully glycosylated cotransporter delivered to the plasma membrane (20) . A predominant band at 75 kDa corresponds to the molecular mass of most PKC isotypes. Indeed, PKC-␦ was detected in immunoprecipitates of NKCC1 (Fig. 6 ). More importantly, NKCC1 was detected in immunoprecipitates of PKC-␦. In these experiments, coimmunoprecipitation of PKC-␦ and NKCC1, taken together with previous reports of ␣-adrenergic effects on PKC-␦ activity and subcellular localization that coincide with ␣-adrenergic stimulation of NKCC1 function (11, 13) , indicates a physiologically relevant association.
DISCUSSION
[Cl
Ϫ ] i has been linked to regulation of NKCC1 in a number of cells and tissues including secretory epithelia, avian erythrocytes, and squid axon (1, 6, 24) . This study of Calu-3 airway epithelial cells demonstrates for the first time that a Cl i Ϫ electrochemical gradient alone is not sufficient to stimulate NKCC1 activity; rather, elevated activity of PKC-␦ is necessary. Increasing [Cl Ϫ ] i , independent of changes in cell volume, correlates with shifts in the subcellular localization of PKC-␦ and -(see Fig. 5 ) and in the activity and regulation of PKC-␦ and NKCC1 by the ␣ 1 -adrenergic agonist methoxamine (see Figs. 3 and 4) . Titration of . PKC-␦ coimmunoprecipitates with NKCC1. Cell monolayers were grown to confluence on filter inserts and were serum deprived overnight. Total cell lysates were prepared in NKCC1 lysis buffer. PKC-␦ and NKCC1 immunoprecipitated from equal aliquots of total cell lysate. Immune complexes were subjected to SDS-PAGE on 4-15% gradient slab gels. Protein stain was performed using a silver stain kit. Western blot analyses for NKCC1 and PKC-␦ in immune complexes (IP) and total cell lysates (LYS) are typical for 3 independent experiments. In the absence of primary antibody, there were no detectable protein bands that were immunoreactive with antisera. Pretreatment of total cell lysates with agarose beads before addition of primary antibody to reduce nonspecific binding yielded the same results. (6, 21) . In these other systems, the dependence on [Cl Ϫ ] i is biphasic and shows stimulation with increasing [Cl Ϫ ] i from 0 to 40 mM followed by inhibition. The response of Calu-3 cells cannot be explained by a change in cell volume (see Table 1 ) or by an increase in PKC-␦ activity (see Fig. 4 ). One explanation could be the sensitivity of NKCC1-regulated K ϩ flux to intracellular electrolyte concentration, or conversely water content, which has been postulated to reflect the dependence of thermodynamic activity of intracellular proteins on total protein concentration or macromolecular crowding (18) . Macromolecular crowding decreases the dissociation rate constants of protein complexes leading to prolonged formation of complexes (23) ] i to 200 mM also enhanced translocation of PKC-␦ and -from the cytosol to the cell periphery (see Fig. 5 ). Translocation did not, however, lead to a significant increase in enzyme activity, nor did it prevent a methoxamine-induced increase in the activity of PKC-␦ (see Fig. 4 ). These results indicate that Calu-3 cells resemble human tracheal epithelial cells (13) and a CF/T43 airway epithelial cell line (12) , which exhibit an approximately even distribution of PKC-␦ between the cytosol and a particulate fraction and a predominantly cytosolic localization of PKC-. With Calu-3 cells, we speculate that macromolecular crowding at high [Cl Ϫ ] i promotes protein-protein interactions, which lead to the association of PKC with a particulate subcellular fraction with slight or no increase in PKC activity. One indication of a proteinprotein interaction is the coimmunoprecipitation of PKC-␦ with NKCC1 and vice versa (see Fig. 6 (22) using a rat salivary acinar cell preparation was consistent with the conclusion that a decrease in Cl i Ϫ is necessary but not sufficient for activation of NKCC1. In our studies, we isolated the activation of NKCC1 from cAMP-dependent secretion by using a NKCC1-selective activator, methoxamine. Our results indicate, for the first time, that ␣ 1 -adrenergic activation of NKCC1 is sensitive to a fall in [Cl Ϫ ] i, but requires stimulation of PKC-␦ activity. The results have important implications for diseases such as cystic fibrosis in which the apparent secretory capacity of airway epithelium is defective. Studies by Slotki and colleagues (27) using CFPAC cells, which are derived from pancreatic adenocarcinoma of a cystic fibrosis patient, demonstrate that secretory capacity can be limited by low cotransporter activity. This implies that genetic approaches to correct cystic fibrosis transmembrane conductance regulator levels to improve secretory capacity will depend, for success, on optimal functioning of NKCC1. Understanding intracellular mechanisms leading to activation of NKCC1 is thus critical for successful development of new therapeutics to correct secretion in cystic fibrosis.
From previous studies (9, 10), we predicted agonistinduced increases in V i and Cl i Ϫ due to increased influx via NKCC1. The data of Fig. 1 and Table 2 support this prediction and show in addition that NKCC1 expressed in Calu-3 cells can be activated by hyperosmotic stress (see Fig. 2 ), which is a response shared by epithelial cells of alveolus (2), kidney (26) , colon (16) , and pancreas (17) . In addition, the data show that Calu-3 cells act as osmometers but lose water slowly. Inhibition of NKCC1 caused a prolonged recovery of V i (see Fig. 2) ; hence, [Cl Ϫ ] i appears to be necessary for recovery from hyperosmotic stress. In cystic fibrosis and other pulmonary diseases, an increased osmolarity of a mucociliary fluid layer, due to lack of sufficient fluid secretion, hypersecretion of proteins or mucus, bacterial infection, or an enhanced inflammatory response, might induce alterations in epithelial [Cl Ϫ ] i that limit the level of NKCC1 activity with consequences for the ability of epithelial cells to mount a defense through increased fluid secretion. Successful therapeutic approaches to restore or stimulate secretory capacity must take into account any sensitivity toward Cl i Ϫ -sensitive regulation of NKCC1 to achieve optimal secretion.
